Rising Insurance Costs
Small towns that added GLP-1 weight-loss drugs to employee health insurance plans are facing huge, unexpected premiums.
12The Journal
As small towns add GLP-1 drugs to employee health plans, unexpected premium hikes are straining local budgets.
Small towns are experiencing significant financial strain due to unexpected increases in health insurance premiums driven by the growing use of GLP-1 weight-loss drugs.
12Prepared by GenPodAI-assisted and grounded in publisher-provided material
Small towns that added GLP-1 weight-loss drugs to employee health insurance plans are facing huge, unexpected premiums.
12Many small towns across the country have incorporated these drugs into their benefits packages, leading to broader economic impacts.
1The episode features insights from a Belchertown, MA selectwoman and WSJ’s Owen Tucker-Smith on the economics affecting towns nationwide.
3Ask GenPod next
“How do GLP-1 drugs impact municipal budgeting?”
“What strategies are towns using to manage rising health insurance costs?”
“How does the adoption of weight-loss drugs vary by region?”
Questions
The continued growth in the use of GLP-1 weight-loss drugs added to employee health insurance plans is driving up costs.
12Imani Moise speaks with a selectwoman from Belchertown, MA, and WSJ’s Owen Tucker-Smith.
3Experts
Sources and disclosure
Primary material
GenPod used an AI-assisted workflow to organize publisher-provided show notes into a listening guide. It is not independent reporting or fact-checking; verify important claims against the source episode.
Read our methodologyReport a correctionThis episode is part of The Journal, featuring reporting from The Wall Street Journal.
GenPod publishes an independent listening guide. Rights in the original podcast audio, artwork, show notes, and trademarks belong to their respective owners.
If you own or represent the rights and believe material on this page is used without authorization, request review or removal. Include the original work, the material at issue, and your contact information.
Many small towns across the country added GLP-1 weight-loss drugs to their employee health insurance plans.
Now, some of those towns are being hit with huge unexpected premiums as use of the drugs continues to grow.
Imani Moise speaks to a selectwoman from Belchertown, MA who helped navigate her town through a devastating bill and WSJ’s Owen Tucker-Smith takes us through the economics for towns around the country.
Further Listening:
- Trillion Dollar Shot
- Novo Nordisk's CEO Has a Comeback Plan
- Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out?
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Related listening guides